Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 06, 2015 2:16 AM ET

Healthcare Equipment and Supplies

Company Overview of ExThera Medical Corporation

Company Overview

ExThera Medical Corporation develops extracorporeal devices to modulate and down-regulate the inflammatory response in various disease states. The company’s devices also capture and remove pathogens from circulating blood, which underlies the original disease process. Its product includes Selective Removal by Apheresis, which is used in an extracorporeal circuit in which blood is removed from a patient, as well as passes through the hemofilter and returns to the patient. The company is also involved in developing clinical trial platforms that addresses sepsis and septic shocks, cardiogenic shocks, crohn’s and inflammatory bowel diseases, other autoimmune diseases, and infections caused by pa...

813 Heinz Avenue

Berkeley, CA 94710

United States

Founded in 2007

Phone:

510-809-2500

Fax:

510-809-2510

Key Executives for ExThera Medical Corporation

Chairman of the Board, Chief Executive Officer and President
Executive Vice President and Director
Vice President of Research & Development and Director
Medical Advisor
Medical Advisor
Compensation as of Fiscal Year 2014.

ExThera Medical Corporation Key Developments

ExThera Medical Corporation Appoints John W. Feik to Board of Directors

ExThera Medical Corporation announced that it has appointed John Feik to its board of directors, effective immediately. His most recent position was President and Chief Operating Officer of DFB Pharmaceuticals Inc.

ExThera Medical LLC Presents at IN3 Medical Device 360° Summit, Oct-17-2013 02:20 PM

ExThera Medical LLC Presents at IN3 Medical Device 360° Summit, Oct-17-2013 02:20 PM. Venue: InterContinental Mark Hopkins, 999 California Street, San Francisco, CA 94108, United States.

Exthera Medical and BioBridge Global to Collaborate in Research Program

ExThera Medical announced that it is partnering with BioBridge Global in a research and development collaboration to evaluate new methods for the removal of bacteria and viruses from human banked blood and blood product, using ExThera's broad-spectrum, biomimetic sorption hemoperfusion technology.

Similar Private Companies By Industry

Company Name Region
MTS Medication Technologies, Inc. United States
Shape Memory Therapeutics, Inc. United States
Siesta Medical, Inc. United States
Summetria LLC United States
ImmunoVision, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 6, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ExThera Medical Corporation, please visit www.extheramedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.